15 June 2022

EPAM Attorneys Protect an International Flooring Market Leader Before the FAS Russia

EPAM Competition Law Practice has protected an international flooring market leader by proving the anti-competitive nature of the franchising agreements and bonus programs of its competitor Tarkett, the largest Russian linoleum manufacturer.

9 June 2022

EPAM Attorneys Advise on M&A Deal Between the Leading Abu Dhabi Energy Company TAQA and British Engineering Company Tendeka.

EPAM provided comprehensive legal support on the Russian legal aspects of a cross-border M&A transaction between TAQA, the National Energy Company of Abu Dhabi (UAE), and Tendeka, the leading British engineering company present in the US, the UK, China, Australia, Canada, the UAE, Malaysia and the EU.

8 June 2022

EPAM Attorneys Represented the Interests of Northern Capital Gateway Consortium

7 June 2022

Ekaterina Verle Joins EPAM Real Estate and Construction Practice Team

6 June 2022

Dmitriy Glazounov Elected to the Expert Council on Listing of the Moscow Exchange (MOEX)

On May 30, 2022, the Moscow Exchange Executive board formed a new board of members of the Expert Council on Listing. Dmitriy Glazounov, Partner, Head of Banking & Finance Law and Capital Markets Practice at EPAM, was elected to the Council as a legal expert.

26 May 2022

EPAM Attorneys Advised Commercial Metals Company During the Acquisition of TAC Acquisition Corp. (“Tensar”)

EPAM advised on the Russian aspects of the USD550m acquisition of Tensar – a portfolio company of Castle Harlan Inc.'s funds, and the world-leader in the manufacture and supply of retaining walls, ground stabilisation and soil reinforcement solutions across 80 national markets – by Commercial Metals Company, US steel and metal manufacturer. The transaction was multi-jurisdictional and included Tensar companies in the US, Europe, China, Russia.

18 April 2022

EPAM Attorneys Continue to Successfully Defend the Interests of Novartis in a Case Involving Unfair Competition on the Part of the Distributor of the Generic Nilotinib Drug

On April 18, 2022, the Ninth Arbitrazh Court of Appeal upheld the decision of the Moscow Arbitrazh Court, which ruled in favour of the international pharmaceutical corporation Novartis, which was represented by the legal team of EPAM. The court rejected Mammoth Pharm's demands to cancel both the decision and order of the Federal Antimonopoly Service in a high-profile case of unfair practices of a generic drug distributor who was producing generics in violation of a patent.

5 April 2022

EPAM Attorneys Advised German Digital Health Company Vivira on Intellectual Property Issues    

EPAM assisted Vivira (the German Medtech company, specialising in the development of software for digital healthcare) in concluding an agreement with Russian developers.

1 April 2022

EPAM Attorneys Advised German IT Company on a Complicated Case on Trading Used Software Under the Russian Law

According to the European rules and case law, if the distribution right to the copy of a software program has been exhausted, the original purchaser can sell the software to a third party, whereas the creator of the software cannot prevent such a sale.

24 March 2022

A Top Manager of a Foreign Company Was Released From Custody Thanks to the Efforts of the Firms’s White Collar Crime Practice Which Achieved Victory Before the Court of Appeals

11 March 2022

EPAM Attorneys Provided Legal Assistance to AIK Banka, Gorenjska Banka and Agri Europe Cyprus in acquisition of shares of financial institutions in Central and Eastern Europe

EPAM’ attorneys provided legal assistance to European banks – AIK Banka, Gorenjska Banka and Agri Europe Cyprus – on Russian aspects of Central and Eastern European financial institutions’ shares’ acquisition. The overall value of the transaction totaling EUR 7.3 bn.

2 March 2022

EPAM Advises French Group BRIAND in Its Acquisition of the Russian Subsidiary Astron From Swedish Lindab Group as Part of a Cross-Border M&A Transaction

EPAM represented French Groupe BRIAND in its acquisition of the Russian subsidiary Astron from Swedish Lindab Group as part of a cross-border transaction. Groupe BRIAND acquired from Lindab Group companies and assets in the Czech Republic, France, Germany, Hungary, Luxembourg, Poland and Russia.

25 February 2022

EPAM Defends the Only Russian Provider of Inmarsat Satellite Services in Multi-Million Dollar Disputes With a Mala Fide Counterparty

EPAM litigation team defended FGUP Morsvyazsputnik, the only Russian provider of Inmarsat satellite services, in disputes with a mala fide counterparty.

24 February 2022

EPAM Attorneys Have Successfully Helped Rusagro Secure Trademark Recognition of the Moscow Provensal Brand

The team of EPAM provided legal support to the Rusagro Group of Companies, the largest vertical agricultural holding in Russia, in securing trademark recognition of the Moscow Provensal brand.

14 February 2022

EPAM Defends Novartis in a Precedent-Setting Case Over Unfair Competition by a Generic Distributor

EPAM’s competition and litigation team of lawyers has successfully defended the interests of multinational pharmaceutical corporation Novartis before the Federal Antimonopoly Service of Russia and in court in a case involving a breach of the competition protection law by a distributor that commercialised a generic drug in an infringement of the patent rights to the original drug formula.